Fiabita
NP

5 Charting Errors That Put NP Prescribing Authority at Risk

Canada · Fiabita · Updated October 3, 2026

Prescribing draws more scrutiny than most clinical decisions. These five gaps weaken the record. They are documentation habits to improve, not predictions of regulatory outcomes.

The short answer

Common gaps: no rationale for the choice, no allergy and interaction review, no record of counselling, refills without reassessment, and unusual dosing without explanation. The College of Nurses of Ontario NP standard, as an example, lists prescription content requirements, counselling on pharmacotherapeutics, and follow-up of test results. Other regulators have their own expectations.

1. No rationale for the choice

Especially when alternatives exist, show why this drug and dose were chosen.

Example

Chose first-line option given normal renal function and no interacting medications; alternative avoided due to patient's previous intolerance.

2. Missing allergy and interaction review

Even if nothing is flagged, record that the review was done: "Allergies reviewed, no known drug allergies; current medications reviewed for interactions."

3. No record of counselling

The CNO standard mentions counselling on rationale, cost, adverse effects, interactions, contraindications and precautions. Record what the patient was told, when to seek help, and any teach-back.

4. Refills without reassessment

Record how the patient is doing on the medication, adherence, side effects, relevant monitoring and your decision to continue, change or stop.

5. Unusual dosing without explanation

If you prescribe outside usual guidance, record the reasoning, source, patient-specific factors and the monitoring plan.

Example (fictional patient)

Prescribing note

Patient Y, 62, hypertension, home BP average 152/90 over 2 weeks. No known drug allergies. Current medications reviewed. Discussed options; patient prefers once-daily dosing. Prescribed [drug and dose per local guidance], directions written, quantity and refills per policy. Counselled on purpose, possible side effects, when to call, and to avoid missed doses. Follow-up BP check and blood test in 4 weeks; patient will be contacted with results by phone.

Template

Indication: ___ Drug, dose, route, frequency, duration: ___ Rationale and alternatives considered: ___ Allergy and interaction review: ___ Counselling: ___ Monitoring and follow-up (owner, date): ___ Patient understanding: ___

Where Fiabita fits

Fiabita's "Clean up my note" tool can help you reword rough notes into clearer, more objective language, and its SBAR handoff and incident-report tools ask guided questions so fewer details get lost under pressure. The output is a draft: you remain responsible for what goes into the record, and it does not check compliance with your regulator or employer. Do not enter information that could identify a real patient, and follow your workplace policy on which tools may be used.

FAQ

Q: Does routine prescribing need this much detail every time?
Not necessarily. Use your judgment and local standards. The more unusual or higher-risk the decision, the more reasoning belongs in the record.

Q: What is the fastest way to build the habit?
Use a short template for prescribing notes, and review one note a week against it.

Q: Is this legal advice?
No. Check your regulator's NP standard and consult your employer or professional liability provider.

Sources and further reading

Always check the current version of each source and your own regulator's standards; links and wording can change.

Educational content only. This is not legal, regulatory or clinical advice. Requirements differ by province, regulator, role and employer, so check the current standard and your workplace policy before applying anything here.

Try Fiabita · Back to the Healthcare Hub · Terms · Privacy